Synlett 2015; 26(09): 1195-1200
DOI: 10.1055/s-0034-1380348
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis and Antimicrobial/Cytotoxic Assessment of Ferrocenyl Oxazinanes, Oxazinan-2-ones, and Tetrahydropyrimidin-2-ones

Anka Pejović
a   SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium
b   Department of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia
,
Barbara Danneels
c   Centre for Industrial Biotechnology and Biocatalysis, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium
,
Tom Desmet
c   Centre for Industrial Biotechnology and Biocatalysis, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium
,
Ba Thi Cham
d   Institute of Chemistry, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
,
Tuyen Van Nguyen
d   Institute of Chemistry, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam
,
Niko S. Radulović
e   Department of Chemistry, Faculty of Science and Mathematics, University of Niš, Visegradska 33, 18000 Niš, Serbia
,
Rastko D. Vukićević*
b   Department of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia
,
Matthias D’hooghe*
a   SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 12. Januar 2015

Accepted after revision: 16. Februar 2015

Publikationsdatum:
19. März 2015 (online)


Abstract

3-Arylamino-1-ferrocenylpropan-1-ones, prepared through aza-Michael addition of aromatic amines to 1-ferrocenylpropenone, were transformed into the corresponding 1,3-amino alcohols upon NaBH4-mediated carbonyl reduction. The latter amino alcohols were deployed as eligible substrates for the synthesis of a variety of ferrocene-containing heterocycles including 1,3-oxazinanes, 1,3-oxazinan-2-ones, and tetrahydropyrimidin-2-ones, which were subsequently evaluated for their antimicrobial and cytotoxic activities.

 
  • References and Notes

  • 2 For a review, see: Fouda MF. R, Abd-Elzaher MM, Abdelsamaia RA, Labib AA. Appl. Organomet. Chem. 2007; 21: 613
  • 3 For a recent review, see: Quirante J, Dubar F, Gonzalez A, Lopez C, Cascante M, Cortes R, Forfar I, Pradines B, Biot C. J. Organomet. Chem. 2011; 696: 1011
  • 4 For a review, see: Scutaru D, Tataru L, Mazilu I, Vata M, Lixandru T, Simionescu C. Appl. Organomet. Chem. 1993; 7: 225
  • 5 For a recent review, see: Braga SS, Silva AM. S. Organometallics 2013; 32: 5626
  • 6 For a recent review, see: Pereira CM. P, Venzke D, Trossini GH. G. Quim. Nova 2013; 36: 143
    • 7a Damljanović I, Stevanović D, Pejović A, Vukićević M, Novaković SB, Bogdanović GA, Mihajlov-Krstev T, Radulović N, Vukićević RD. J. Organomet. Chem. 2011; 696: 3703
    • 7b Pejović A, Denić MS, Stevanović D, Damljanović I, Vukićević M, Kostova K, Tavlinova-Kirilova M, Randjelović P, Stojanović NM, Bogdanović GA, Blagojević P, D’hooghe M, Radulović NS, Vukićević RD. Eur. J. Med. Chem. 2014; 83: 73
    • 7c Radulović NS, Zlatković DB, Mitić KV, Randjelović PJ, Stojanović NM. Polyhedron 2014; 80: 134
    • 7d Pejović A, Damljanović I, Stevanović D, Vukićević M, Novaković SB, Bogdanović GA, Radulović N, Vukićević RD. Polyhedron 2012; 31: 789
    • 7e Damljanović I, Vukićević M, Radulović N, Palić R, Ellmerer E, Ratković Z, Joksović MD, Vukićević RD. Bioorg. Med. Chem. Lett. 2009; 19: 1093
    • 7f Ilić D, Damljanović I, Stevanović D, Vukićević M, Blagojević P, Radulović N, Vukićević RD. Chem. Biodiversity 2012; 9: 2236
    • 7g Radulović NS, Mladenović MZ, Stojanović-Radić Z, Bogdanović GA, Stevanović D, Vukićević RD. Mol. Diversity 2014; 18: 497
    • 7h Damljanović I, Stevanović D, Pejović A, Ilić D, Živković M, Jovanović J, Vukićević M, Bogdanović GA, Radulović NS, Vukićević RD. RSC Adv. 2014; 4: 43792
  • 9 For a review, see: Lait SM, Rankic DA, Keay BA. Chem. Rev. 2007; 107: 767
  • 10 6-Ferrocenyl-3-phenyl-1,3-oxazinane (6a) Yield 78%, dark yellow solid; mp 86 °C. 1H NMR (400 MHz, CDCl3): δ = 7.34–7.27 (m, 2 H), 7.13–7.09 (m, 2 H), 6.93–6.87 (m, 1 H), 5.30 (dd, J = 10.7, 2.3 Hz, 1 H), 4.74 (d, J = 10.7 Hz, 1 H), 4.48 (dd, J = 11.2, 2.4 Hz, 1 H), 4.22 (ca. dt, J = 2.5, 1.3 Hz, 1 H), 4.17 (ca. dt, J = 2.5, 1.3 Hz, 1 H), 4.15–4.07 (m, 2 H), 4.12 (s, 5 H), 3.91 (ddt, J = 13.5, 4.3, 2.3 Hz, 1 H), 3.49 (ddd, J = 13.5, 12.7, 2.9 Hz, 1 H), 2.02 (dddd, J = 13.1, 12.7, 11.2, 4.3 Hz, 1 H), 1.78 (ddt, J = 13.1, 2.9, 2.4 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 148.9, 129.1, 120.5, 118.4, 88.9, 81.3, 76.0, 68.6, 68.0, 67.8, 67.3, 66.0, 49.9, 29.2. MS (ES+): m/z = 348.1 [MH+]. Column chromatography (SiO2): hexane–EtOAc, 8:2 (v/v). ESI-HRMS: m/z calcd for C20H22FeNO [M + H]+: 348.1050; found: 348.1041.
  • 11 Cassady JM, Chan KK, Floss HG, Leistner E. Chem. Pharm. Bull. 2004; 52: 1
  • 12 Meyers AI, Roland DM, Comins DL, Henning R, Fleming MP, Shimizu K. J. Am. Chem. Soc. 1979; 101: 4732
  • 13 Gormley GJr, Chan YY, Fried J. J. Org. Chem. 1980; 45: 1447
  • 14 Widdison WC, Wilhelm SD, Cavanagh EE, Whiteman KR, Leece BA, Kovtun Y, Goldmacher VS, Xie H, Steeves RM, Lutz RJ, Zhao R, Wang L, Blaettler WA, Chari RV. J. J. Med. Chem. 2006; 49: 4392
  • 15 D’hooghe M, Dekeukeleire S, Mollet K, Lategan C, Smith PJ, Chibale K, De Kimpe N. J. Med. Chem. 2009; 52: 4058
  • 17 6-Ferrocenyl-3-phenyl-1,3-oxazinan-2-one (8a) Yield 64%, yellow solid; mp 148 °C. 1H NMR (400 MHz, CDCl3): δ = 7.43–7.38 (m, 2 H), 7.37–7.33 (m, 2 H), 7.29–7.24 (m, 1 H), 5.31 (dd, J = 9.5, 3.0 Hz, 1 H), 4.36 (ca. dt, J = 2.5, 1.3 Hz, 1 H), 4.28 (ca. dt, J = 2.5, 1.3 Hz, 1 H), 4.23–4.19 (m, 2 H), 4.24 (s, 5 H), 3.81 (ddd, J = 11.7, 10.2, 4.9 Hz, 1 H), 3.70 (ddd, J = 11.7, 5.5, 4.1 Hz, 1 H), 2.45 (dddd, J = 13.8, 4.9, 4.1, 3.0 Hz, 1 H), 2.28 (dddd, J = 13.8, 10.2, 9.5, 5.5 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 152.8, 143.1, 129.4, 126.9, 126.0, 86.3, 76.2, 69.1, 68.5, 68.4, 67.4, 66.1, 47.9, 28.9. IR (ATR): ν = 1685 (C=O) cm–1. MS (ES+): m/z = 362.1 [MH+]. Column chromatography (SiO2): hexane–EtOAc, 8:2 (v/v). ESI-HRMS: m/z calcd for C20H20FeNO2 [M + H]+: 362.0844; found: 362.0834.
  • 19 Davies SG, Garner AC, Robert PM, Smith AD, Sweet MJ, Thomson JE. Org. Biomol. Chem. 2006; 4: 2753
  • 21 4-Ferrocenyl-3-isopropyl-1-phenyltetrahydropyrimidin-2-one (10a) Yield 61%, orange liquid. 1H NMR (400 MHz, CDCl3): δ = 7.34–7.27 (m, 2 H), 7.25–7.20 (m, 2 H), 7.16–7.09 (m, 1 H), 4.46 (t, J = 3.9 Hz, 1 H), 4.24 (d × t, J = 2.4, 1.2 Hz, 1 H), 4.20–4.09 (m, 3 H), 4.16 (s, 5 H), 4.13–4.10 (m, 1 H), 3.62–3.46 (m, 2 H), 2.33–2.15 (m, 2 H), 1.37 (d, J = 6.8 Hz, 3 H), 1.28 (d, J = 6.8 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 154.5, 144.3, 128.8, 126.0, 125.2, 91.2, 69.4, 68.9, 68.4, 66.7, 66.0, 53.0, 50.9, 45.2, 31.7, 21.3, 20.9. IR: ν = 1636 (C=O) cm–1. MS (ES+): m/z = 403.2 [M + H]+. Preparative chromatography (SiO2): hexane–EtOAc, 6:4 (v/v). ESI-HRMS: m/z calcd for C23H27FeN2O [M + H]+: 403.1473; found: 403.1475.
  • 22 Natarajan SR, Doherty JB. Curr. Top. Med. Chem. 2005; 5: 987
  • 23 James CA, DeRoy P, Duplessis M, Edwards PJ, Halmos T, Minville J, Morency L, Morin S, Simoneau B, Tremblay M, Bethell R, Cordingley M, Duan JM, Lamorte L, Pelletier A, Rajotte D, Salois P, Tremblay S, Sturino CF. Bioorg. Med. Chem. Lett. 2013; 23: 2781
    • 24a NCCLS. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline. NCCLS document M44-A [ISBN 1-56238-532-1]. 24, (NCCLS, NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2004)
    • 24b CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition. CLSI document M02-A11. Wayne, 32, (Clinical and Laboratory Standards Institute, 2012)